PFIZER INC. (LON:PFZ) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
On May 2, 2017, Pfizer Inc. (Pfizer) issued a press release
announcing its financial results for first-quarter 2017. A copy
of the press release is furnished herewith as Exhibit 99 and is
incorporated by reference herein.
announcing its financial results for first-quarter 2017. A copy
of the press release is furnished herewith as Exhibit 99 and is
incorporated by reference herein.
The information furnished to this Item 2.02 – Results of
Operations and Financial Condition, including Exhibit 99, shall
not be deemed to be filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (Exchange Act) or
otherwise subject to the liabilities of that section, and shall
not be deemed to be incorporated by reference into any filing
made by us under the Exchange Act or Securities Act of 1933, as
amended, regardless of any general incorporation language in any
such filing, except as shall be expressly set forth by specific
reference in such filing.
Operations and Financial Condition, including Exhibit 99, shall
not be deemed to be filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (Exchange Act) or
otherwise subject to the liabilities of that section, and shall
not be deemed to be incorporated by reference into any filing
made by us under the Exchange Act or Securities Act of 1933, as
amended, regardless of any general incorporation language in any
such filing, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit Number
|
Exhibit Description
|
|
|
Exhibit 99 –
|
Press Release of Pfizer Inc. dated May 2, 2017,
reporting
Pfizers financial results for first-quarter 2017.
|
PFIZER INC. (LON:PFZ) Recent Trading Information
PFIZER INC. (LON:PFZ) closed its last trading session at 0.00000 with 0 shares trading hands.
